Top Super Bowl Fact...
Health Care: Drugs
NeurogesX Inc. (NGSX: NASDAQ)
$0.80 -0.08 | -8.99%
02/08/12 - 04:00 PM ET
546.59K / 144.70K
Vol / Avg. Vol:0.86 / 0.88
Open / Prev. Close:0.77 - 0.90
Today's Range:0.66 - 5.80
52 Wk Range:-2.61%
Performance YTD:TheStreet Rating:
Portfolios with NGSX
- Portfolio NameUser Type
- Contributor5 Health Care Stocks With U...
- Contributor10 Biotech Stocks Expected ...
- UserSUPRATRADE STRONG BUY-25090...
- ContributorCharts of the Week - 7-22-2009
- UserBENITRANS IH
- Userirvgruve Portfolio 1
- UserBarron's Research Reports 6...
- Userrick ebenstein Portfolio 1
Latest NGSX Headlines from TheStreet
- Insiders Trading TXI, P, NGSX, CNK 06.21.11 | 09:06 am
- 5 Health Care Stocks With Upside 03.21.11 | 11:03 am
- 10 Biotech Stocks Expected to at Least Double 10.19.10 | 06:10 am
- Stock Offerings: Kodiak Oil & Gas 08.13.10 | 09:08 am
- NeurogesX Inc. Q1 2010 Earnings Call Transcript 05.11.10 | 10:05 pm
- Earnings Roundup: Palm, Cintas 03.18.10 | 06:03 pm
- Trading Smallcap Biotech
02.01.10 | 09:02 am - NeurogesX Shares Rise Following FDA Approval 11.17.09 | 12:11 pm
- NeurogesX Gets FDA Approval For Pain Patch 11.16.09 | 06:11 pm
- CEO Sells $10.8M Worth of Guess 09.18.09 | 09:09 am
Press Releases for NGSX
- Qutenza(R) (capsaicin) 8% Patch For Treatment Of Post-Shingles Pain Now Available - PR Newswire 04.05.10 | 08:04 am
- NeurogesX To Present At BioCentury Future Leaders In The Biotech Industry Conference - PR Newswire 04.01.10 | 01:04 pm
Partner Headlines for NGSX
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Market Gives Up Gains Ahead of House Vote - Benzinga 07.28.11 | 04:07 pm
- Morning Market Movers - Benzinga 06.16.11 | 09:06 am
- Biotech CROs Take Center Stage in Recent Deals - Seeking Alpha 05.02.10 | 05:05 am
- UPDATE 1-NeurogesX says shingles-pain patch available, shares up - Reuters 04.05.10 | 02:04 pm
- Volume Talks Wednesday: A Bullish Biotech Breakout Option Play - SeekingAlpha.com 03.25.10 | 12:03 am
